Stay updated on Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial

Sign up to get notified when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the Nelotanserin study in Lewy body dementia is available, with details on the trial design, participant eligibility, study locations, and measured outcomes.
    Difference
    46%
    Check dated 2026-11-09T13:46:48.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:44:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s website transition and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T14:57:13.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:46:10.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:47:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details. The visible content shows the 403 notice while the rest of the page layout remains, indicating an access issue rather than a substantive update to the study information.
    Difference
    17%
    Check dated 2026-09-21T22:05:42.000Z thumbnail image

Stay in the know with updates to Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.